Loading...
XSHE
002326
Market cap2.84bUSD
Jul 10, Last price  
20.01CNY
1D
-3.84%
1Q
-14.92%
Jan 2017
37.48%
IPO
303.77%
Name

Zhejiang Yongtai Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002326 chart
P/E
P/S
3.55
EPS
Div Yield, %
Shrs. gr., 5y
1.02%
Rev. gr., 5y
3.13%
Revenues
5.21b
+13.60%
288,541,961393,072,284492,811,079511,034,881725,759,212838,874,860769,622,8071,061,449,3411,542,012,5781,748,536,2672,751,122,3063,295,273,7923,429,842,4323,450,306,5494,468,739,4444,468,739,4446,321,219,7294,128,040,8194,589,397,8325,213,581,336
Net income
-46m
L-90.36%
41,149,06243,283,98657,242,92658,318,89063,709,36064,345,32119,848,26483,342,436144,265,027277,018,949182,236,152441,660,047271,699,333120,003,658280,285,674280,285,683554,106,178-619,761,431-478,353,978-46,100,648
CFO
-72m
L-35.03%
25,206,37615,126,03962,683,83268,107,426-3,125,324099,803,86322,253,631166,637,10966,258,15184,232,45919,570,675719,671,411382,071,954345,147,877576,003,356223,682,226-329,126,584-110,869,010-72,031,284
Dividend
May 25, 20230.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Yongtai Technology Co., Ltd. engages in the production, research, development, sale, and service of medicines, pesticides, electronic chemicals, and new energy lithium battery materials. Its products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, advanced intermediates, basic intermediates, pesticides, liquid crystal materials, and lithium battery materials. It also provides contract manufacturing services. The company was founded by Ying Mei Wang and Ren Bao He on October 11, 1999 and is headquartered in Taizhou, China.
IPO date
Dec 22, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT